Article 1 to 1 out of 1 concerning DAKO Diagnostika GmbH
DakoCytomation signs agreement on novel prostate cancer markers(09/11/2003) CARPINTERIA, CA, US - DakoCytomation has received exclusive worldwide rights to two antibodies that hold promise for prostate cancer diagnostics and monitoring. Under a licensing agreement with immunotherapeutics developer Corixa Corporation ...
Top
